CORONAVIRUS DISEASE COVID 19 NEWS AND RESEARCH
Latest Coronavirus Disease COVID 19 News and Research
New diagnostic tool may allow on-the-spot detection of coronavirus infection
Scientists at the University of Warwick have demonstrated that a potential diagnostic tool for detecting Covid-19 using sugars will work with a virus rather than just its proteins, a significant step in making it a viable test in future.
ZwickRoell Supports Testing of Personal Protective Equipment (PPE) and Primary Packaging for COVID-19 Vaccines
COVID-19 has a big impact on our daily lives and has changed the landscape of the medical and pharmaceutical industries.
Melt Flow Testing Supports the Fight Against Covid-19
ZwickRoell is proud to support the production of PPE through easy-to-use and reliable testing instruments.
ZwickRoell’s zwickiLine Testing System Validated for Cleanroom Use
The importance of cleanrooms is currently in the spotlight as the global community awaits a vaccine for Covid-19.
D614G mutation now the dominant variant in the global COVID-19 pandemic
Now, a new study published on the preprint server medRxiv in September 2020 shows that a significant variant characterized by the D614G mutation has higher infectivity, which may account for its rapid rise to the dominant position in all regions where it has emerged.
Study: Carriers of genetic mutations have greater risk of illness and death from COVID-19
Tel Aviv University researchers suggest that carriers of the genetic mutations PiZ and PiS are at high risk for severe illness and even death from COVID-19. These mutations lead to deficiency in the alpha1-antitrypsin protein, which protects lung tissues from damage in case of severe infections.
About 10% patients with severe disease create auto-antibodies that attack the immune system
People infected by the novel coronavirus can have symptoms that range from mild to deadly. Now, two new analyses suggest that some life-threatening cases can be traced to weak spots in patients' immune systems.
Inflammation in the eye after COVID-19
A new study published on the preprint server medRxiv shows the occurrence of ocular pathology in the period of recovery following COVID-19. This throws more light on the occurrence of inflammation in people recovering from COVID-19.
BIOCAD to produce liquid vaccine for COVID-19 treatment
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus.
Berlin researchers are pursuing the development of passive vaccination
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.
Human-to-cat transmission of SARS-CoV-2 confirmed
Cat-to-cat transmission of SARS-CoV-2 has been experimentally proven, but little is known about the significance of this novel virus as a feline pathogen or its reverse zoonotic potential. The establishment of new animal reservoirs of SARS-CoV-2 could pose serious problems for human health in the future.
India and Denmark to benefit from NTNU COVID-19 tests
A highly sensitive COVID-19 test, developed by researchers from the Norwegian University of Science and Technology (NTNU), relies on magnetic nanoparticles to extract viral RNA.
A possible inverse relationship between Dengue and COVID-19 in Brazil
Their study titled, “How super-spreader cities, highways, hospital bed availability, and dengue fever influenced the COVID-19 epidemic in Brazil,” was released pre-peer review on the preprint medRxiv* early this week.
Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus
Nine months into the global pandemic, which has infected more than 32 million people, there is still no approved effective and safe drug or vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Linoleic acid binds SARS-CoV-2 spike protein
Now, a team of researchers at the Max Planck-Bristol Center for Minimal Biology and Bristol's School of Biochemistry has identified a druggable pocket in the virus's spike protein that can be used to prevent the infection of cells. The study findings, published in the journal Science, are a groundbreaking discovery that will help develop new therapies and drugs to stem the growing pandemic.
_c6274c997e714f48adbf7011cc8633e9-150x125.jpg "School re-openings in US may increase COVID-19 spread unless targeted interventions are in place")
School re-openings in US may increase COVID-19 spread unless targeted interventions are in place
In a new study published on the preprint server medRxiv, a team of researchers on behalf of the Imperial College London COVID-19 Response Team used longitudinal and age-specific population mobility and COVID-19 mortality data to model and predict SARS-CoV-2 spread in the US.
Carers of adults with intellectual disability report higher rates of lockdown mental health problems
Family carers for children and adults with intellectual disabilities have reported rates of mental health problems under lockdown that are up to 10 times higher than parents without those responsibilities, a new study has found.
Cold plasma inactivates SARS-CoV-2
In one such effort, Zhitong Chen et al., in a recent medRxiv* preprint paper find that by employing an efficient cold atmospheric plasma (CAP) with argon feed gas on different surfaces inactivates the infectious SARS-CoV-2 virus.
Navy lab develops long range temperature scanning sensor system
A federal research facility in Crane, Indiana, has developed a temperature scanning sensor system and software to help contain the coronavirus.
Prevalence of SARS-CoV-2 with D614G mutation in a second wave infection in Houston
A recent study reveals that the genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detected in the initial phase of coronavirus disease 2019 (COVID-19) pandemic differ from the variants detected in a massive second wave of infection in Houston, Texas. The study is currently available on the medRxiv preprint server.
.png)
No hay comentarios:
Publicar un comentario